Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THB335 Phase 1 in Healthy Volunteers
NCT06425861Phase 1Completed
- Sponsor
- Third Harmonic Bio
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of THB335 (6 arms), sponsored by Third Harmonic Bio. Primary endpoint: Treatment-Related Adverse Events. Started May 2024; status: completed.
02
Drugs
THB335
Beyond the preview
Go deeper on NCT06425861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06425861.